MARKET TRENDS
2 Sep 2025
PARTNERSHIPS
29 Aug 2025
TECHNOLOGY
21 Aug 2025
REGULATORY
17 Aug 2025
INSIGHTS
14 Aug 2025
Eli Lilly partners with Superluminal to tap Al for faster obesity drug discovery beyond injectables.
PARTNERSHIPS
26 Jul 2025
Lilly's Verve buyout could turn lifelong cholesterol drugs into a one-time genetic fix.
INNOVATION
28 Jun 2025
CTX310 shows up to 86% LDL reduction in early trial, with full results expected in 2025
INNOVATION
25 Jun 2025
Novo's amycretin pill shows big early weight-loss results, hinting at a future beyond injections.
RESEARCH
21 Jun 2025
Vertex's zimislecel left most trial patients insulin-free after a year, but safety risks and scalability remain major hurdles
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.